Vipharm S.A.
PolandAll medications by this manufacturer
-
Ansifora
Form: tablets, film-coated
Active substance Dosage sitagliptin hydrochloride monohydrate 56.69 mg ATC: A10BH01
-
Ansifora
Form: tablets, film-coated
Active substance Dosage sitagliptin hydrochloride monohydrate 113.38 mg ATC: A10BH01
-
Ansifora duo
Form: tablets, film-coated
Active substance Dosage Sitagliptin 50 mg Metformin hydrochloride 1000 mg ATC: A10BD07
-
Aropilo
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 0.285 mg ATC: N04BC04
-
Aropilo
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 0.57 mg ATC: N04BC04
-
Aropilo
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 1.14 mg ATC: N04BC04
-
Aropilo
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 2.28 mg ATC: N04BC04
-
Aropilo
Form: tablets, film-coated
Active substance Dosage ropinirole hydrochloride 5.7 mg ATC: N04BC04
-
Asduter
Form: tablets
Active substance Dosage aripiprazole 10 mg ATC: N05AX12
-
Asduter
Form: tablets
Active substance Dosage aripiprazole 15 mg ATC: N05AX12
-
Asduter
Form: tablets
Active substance Dosage aripiprazole 30 mg ATC: N05AX12
-
Atrozol
Form: tablets, film-coated
Active substance Dosage Anastrozole 1 mg ATC: L02BG03
-
Binabic
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg ATC: L02BB03
-
Binabic
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg ATC: L02BB03
-
Binabic
Form: tablets, film-coated
Active substance Dosage bicalutamide 50 mg ATC: L02BB03
-
Lametta
Form: tablets, film-coated
Active substance Dosage letrozole 2.5 mg ATC: L02BG04
-
Megalia
Form: suspension, oral
Active substance Dosage megestrol acetate 40 mg ATC: L02AB01
-
Naxalgan
Form: capsules, hard
Active substance Dosage pregabalin 75 mg ATC: N02BF02
-
Naxalgan
Form: capsules, hard
Active substance Dosage pregabalin 150 mg ATC: N02BF02
-
Naxalgan
Form: capsules, hard
Active substance Dosage pregabalin 300 mg ATC: N02BF02
-
Olpinat
Form: tablets, film-coated
Active substance Dosage olanzapine 5 mg ATC: N05AH03
-
Olpinat
Form: tablets, film-coated
Active substance Dosage olanzapine 10 mg ATC: N05AH03
-
Pamifos-30
Form: powder and solvent for preparation of infusion solution
Active substance Dosage Pamidronic acid disodium 30 mg ATC: M05BA03
-
Pamifos-60
Form: powder and solvent for preparation of infusion solution
Active substance Dosage pamidronic acid disodium 60 mg ATC: M05BA03
-
Pamifos-90
Form: powder and solvent for preparation of infusion solution
Active substance Dosage Pamidronic acid disodium 90 mg ATC: M05BA03
-
Sunitinib vipharm
Form: capsules, hard
Active substance Dosage sunitinib maleate 16.7 mg ATC: L01EX01
-
Sunitinib vipharm
Form: capsules, hard
Active substance Dosage sunitinib maleate 33.4 mg ATC: L01EX01
-
Sunitinib vipharm
Form: capsules, hard
Active substance Dosage sunitinib 50 mg ATC: L01EX01
-
Zomikos
Form: solution for infusion, concentrate
Active substance Dosage Zoledronic acid 4 mg/5 ml ATC: M05BA08